{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:56:33Z","timestamp":1791420993304,"version":"4.3.3"},"reference-count":73,"publisher":"RCN Publishing Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,22]]},"DOI":"10.7748\/ns.2019.e11249","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T08:50:23Z","timestamp":1547455823000},"page":"44-50","source":"Crossref","is-referenced-by-count":16,"title":["Role of nurses in supporting proactive deprescribing"],"prefix":"10.7748","volume":"34","author":[{"given":"David John","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sion","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4499","reference":[{"issue":"4","key":"key20190222100150_R1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0194599816648298","article-title":"Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews","volume":"155","year":"2016","journal-title":"Otolaryngology \u2013 Head and Neck Surgery"},{"issue":"8","key":"key20190222100150_R2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1503\/cmaj.050837","article-title":"Prioritizing and stopping prescription medicines","volume":"174","year":"2006","journal-title":"Canadian Medical Association Journal"},{"issue":"13","key":"key20190222100150_R3","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1177\/1049732316687732","article-title":"Negotiating \u201cunmeasurable harm and benefit\u201d: perspectives of general practitioners and consultant pharmacists on deprescribing in the primary care setting","volume":"27","year":"2017","journal-title":"Qualitative Health Research"},{"issue":"12","key":"key20190222100150_R4","doi-asserted-by":"crossref","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","year":"2014","journal-title":"BMJ Open"},{"key":"key20190222100150_R5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2296-11-65","article-title":"Qualitative insights into general practitioners views on polypharmacy","volume":"11","year":"2010","journal-title":"BMC Family Practice"},{"issue":"2","key":"key20190222100150_R6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-199914020-00005","article-title":"The epidemiology of serious adverse drug reactions among the elderly","volume":"14","year":"1999","journal-title":"Drugs and Aging"},{"issue":"6984","key":"key20190222100150_R7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.310.6984.923","article-title":"What constitutes good prescribing?","volume":"310","year":"1995","journal-title":"BMJ"},{"issue":"8","key":"key20190222100150_R8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/jgh.13750","article-title":"Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review","volume":"32","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"key20190222100150_R9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","year":"2002","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"key20190222100150_R10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13300-016-0220-9","article-title":"Lack of evidence to guide deprescribing of antihyperglycemics: a systematic review","volume":"8","year":"2017","journal-title":"Diabetes Therapy"},{"key":"key20190222100150_R11","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in adults","volume":"3","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"key20190222100150_R12","volume-title":"British National Formulary. No. 75","author":"British National Formulary","year":"2018"},{"issue":"7","key":"key20190222100150_R13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.12968\/npre.2014.12.7.353","article-title":"Non-medical prescribers and benzodiazepines: a qualitative study","volume":"12","year":"2014","journal-title":"Nurse Prescribing"},{"issue":"5","key":"key20190222100150_R14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2125.2010.03628.x","article-title":"Potentially inappropriate prescribing and cost outcomes for older people: a national population study","volume":"69","year":"2010","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"11","key":"key20190222100150_R15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/phar.1843","article-title":"Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population","volume":"36","year":"2016","journal-title":"Pharmacotherapy"},{"key":"key20190222100150_R16","unstructured":"Canadian Deprescribing Network (2018) Deprescribing Algorithms. www.deprescribingnetwork.ca\/algorithms (Last accessed: 1 November 2018.)"},{"issue":"6","key":"key20190222100150_R17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/hcn035","article-title":"Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease","volume":"101","year":"2008","journal-title":"QJM"},{"issue":"2","key":"key20190222100150_R18","doi-asserted-by":"crossref","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"key20190222100150_R19","doi-asserted-by":"crossref","first-page":"e0174730","DOI":"10.1371\/journal.pone.0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis","volume":"12","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"key20190222100150_R20","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","year":"2017","journal-title":"Canadian Family Physician"},{"issue":"1","key":"key20190222100150_R21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sapharm.2017.01.003","article-title":"Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines","volume":"14","year":"2018","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"4","key":"key20190222100150_R22","doi-asserted-by":"crossref","first-page":"e0122246","DOI":"10.1371\/journal.pone.0122246","article-title":"What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process","volume":"10","year":"2015","journal-title":"PLoS One"},{"issue":"18","key":"key20190222100150_R23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1503\/cmaj.131873","article-title":"Deprescribing for older patients","volume":"186","year":"2014","journal-title":"Canadian Medical Association Journal"},{"issue":"10","key":"key20190222100150_R24","first-page":"923","article-title":"Effects of benefits and harms on older persons\u2019 willingness to take medication for primary cardiovascular prevention","volume":"171","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"key20190222100150_R25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/ebmh.7.2.46","article-title":"Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term","volume":"7","year":"2004","journal-title":"Evidence-Based Mental Health"},{"key":"key20190222100150_R26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-011-1061-0","article-title":"Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals","volume":"67","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"key":"key20190222100150_R27","volume-title":"Good Practice in Prescribing and Managing Medicines and Devices","author":"General Medical Council","year":"2013"},{"key":"key20190222100150_R28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","article-title":"Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials","volume":"204","year":"2014","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"key20190222100150_R29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jgs.14498","article-title":"Use of bladder antimuscarinics in older adults with impaired cognition","volume":"65","year":"2017","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"key20190222100150_R30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1360-0443.2011.03693.x","article-title":"Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood: a randomized controlled double-blinded trial","volume":"107","year":"2012","journal-title":"Addiction"},{"issue":"8","key":"key20190222100150_R31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF03262283","article-title":"Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy","volume":"29","year":"2012","journal-title":"Drugs and Aging"},{"issue":"11","key":"key20190222100150_R32","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s11606-014-2913-y","article-title":"Growing literature, stagnant science? Systematic review, meta-regression and cumulative analysis of audit and feedback interventions in health care","volume":"29","year":"2014","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"key20190222100150_R33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/intqhc\/mzs015","article-title":"Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm","volume":"24","year":"2012","journal-title":"International Journal for Quality in Health Care"},{"issue":"9","key":"key20190222100150_R34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1742-1241.2011.02728.x","article-title":"Symptom change after discontinuation of successful antimuscarinic treatment in patients with overactive bladder symptoms: a randomised, multicentre trial","volume":"65","year":"2011","journal-title":"International Journal of Clinical Practice"},{"issue":"4","key":"key20190222100150_R35","first-page":"277","article-title":"Clinical provider perceptions of proactive medication discontinuation","volume":"21","year":"2015","journal-title":"American Journal of Managed Care"},{"key":"key20190222100150_R36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2014.06.020","article-title":"Quality of life in a cohort of high-dose benzodiazepine dependent patients","volume":"142","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"key20190222100150_R37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sapharm.2015.04.001","article-title":"Factors influencing nurse and pharmacist willingness to take or not take responsibility for non-medical prescribing","volume":"12","year":"2016","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"1","key":"key20190222100150_R38","first-page":"43","article-title":"Tools for assessment of the appropriateness of prescribing and association with patient-related outcomes: a systematic review. Drugs and","volume":"35","year":"2018","journal-title":"Aging"},{"issue":"4","key":"key20190222100150_R39","first-page":"203","article-title":"Efficacy and safety of available therapies in the management of idiopathic overactive bladder: a systematic review of the literature","volume":"27","year":"2017","journal-title":"Progres en Urologie"},{"issue":"2","key":"key20190222100150_R40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ageing\/afu185","article-title":"Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study","volume":"44","year":"2015","journal-title":"Age and Ageing"},{"key":"key20190222100150_R41","volume-title":"Gastro-Oesophageal Reflux Disease and Dyspepsia in Adults: Investigation and Management","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"key20190222100150_R42","unstructured":"National Institute for Health and Care Excellence (2018) Hypnotics and Anxiolytics. bnf.nice.org.uk\/treatment-summary\/hypnotics-and-anxiolytics.html (Last accessed: 11 October 2018.)"},{"key":"key20190222100150_R43","unstructured":"NHS Digital (2018) Prescription Cost Analysis: England 2017. 2017 Data Tables. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/prescription-cost-analysis\/prescription-cost-analysis-england-2017 (Last accessed: 11 October 2018.)"},{"key":"key20190222100150_R44","unstructured":"Nursing and Midwifery Council (2018a) Future Nurse: Standards of Proficiency for Registered Nurses. www.nmc.org.uk\/globalassets\/sitedocuments\/education-standards\/future-nurse-proficiencies.pdf (Last accessed: 11 October 2018.)"},{"key":"key20190222100150_R45","unstructured":"Nursing and Midwifery Council (2018b) Realising Professionalism: Standards for Education and Training. Part 3: Standards for Prescribing Programmes. www.nmc.org.uk\/globalassets\/sitedocuments\/education-standards\/programme-standards-prescribing.pdf (Last accessed: 11 October 2018.)"},{"key":"key20190222100150_R46","article-title":"Educational outreach visits: effects on professional practice and health care outcomes","volume":"4","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"key20190222100150_R47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ageing\/afm189","article-title":"Inappropriate prescribing in the older population: need for new criteria","volume":"37","year":"2008","journal-title":"Age and Ageing"},{"issue":"2","key":"key20190222100150_R48","first-page":"213","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","year":"2015","journal-title":"Age and Ageing"},{"issue":"7","key":"key20190222100150_R49","first-page":"559","article-title":"Managing urinary incontinence in patients with dementia: pharmacological treatment options and considerations. Drugs and","volume":"32","year":"2015","journal-title":"Aging"},{"issue":"3","key":"key20190222100150_R50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis","volume":"82","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"key20190222100150_R51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","year":"2009","journal-title":"Addiction"},{"issue":"7456","key":"key20190222100150_R52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","year":"2004","journal-title":"BMJ"},{"key":"key20190222100150_R53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review","volume":"16","year":"2015","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"10","key":"key20190222100150_R54","first-page":"793","article-title":"Patient barriers to and enablers of deprescribing: a systematic review. Drugs and","volume":"30","year":"2013","journal-title":"Aging"},{"issue":"9","key":"key20190222100150_R55","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jgs.12418","article-title":"People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe","volume":"61","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"key":"key20190222100150_R56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","year":"2017","journal-title":"European Journal of Internal Medicine"},{"issue":"8","key":"key20190222100150_R57","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","year":"2017","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"key20190222100150_R58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/ggi.12451","article-title":"Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: a systematic review","volume":"15","year":"2015","journal-title":"Geriatrics and Gerontology International"},{"key":"key20190222100150_R59","article-title":"Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity","year":"2018","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"1","key":"key20190222100150_R60","first-page":"4","volume":"26","year":"2018","journal-title":"Deprescribing practice at a UK teaching hospital: reactive or proactive? International Journal of Pharmacy Practice"},{"issue":"5","key":"key20190222100150_R61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","year":"2015","journal-title":"JAMA Internal Medicine"},{"key":"key20190222100150_R62","doi-asserted-by":"crossref","first-page":"e003610","DOI":"10.1136\/bmjopen-2013-003610","article-title":"GPs\u2019 perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research","volume":"3","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"key20190222100150_R63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1752-7325.2004.tb02747.x","article-title":"Efficacy of educational interventions targeting primary care providers\u2019 practice behaviors: an overview of published systematic reviews","volume":"64","year":"2004","journal-title":"Journal of Public Health Dentistry"},{"issue":"7","key":"key20190222100150_R64","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13803395.2014.928268","article-title":"The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis","volume":"36","year":"2014","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"4","key":"key20190222100150_R65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jgs.14030","article-title":"Effect of potentially inappropriate use of antimuscarinic medications on healthcare use and cost in individuals with overactive bladder","volume":"64","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"key20190222100150_R66","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1248\/bpb.b14-00191","article-title":"Analysis of the interaction between clopidogrel, aspirin, and proton pump inhibitors using the FDA adverse event reporting system database. Biological and","volume":"38","year":"2015","journal-title":"Pharmaceutical Bulletin"},{"issue":"4","key":"key20190222100150_R67","first-page":"303","article-title":"Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs and","volume":"35","year":"2018","journal-title":"Aging"},{"issue":"2","key":"key20190222100150_R68","first-page":"113","article-title":"Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review","volume":"7","year":"2016","journal-title":"BMJ Supportive and Palliative Care"},{"issue":"4","key":"key20190222100150_R69","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00520-015-2970-8","article-title":"Polypharmacy cut-points in older people with cancer: how many medications are too many?","volume":"24","year":"2016","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"key20190222100150_R70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488611798280933","article-title":"Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability","volume":"6","year":"2011","journal-title":"Current Drug Safety"},{"key":"key20190222100150_R71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.archger.2016.11.006","article-title":"Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: a systematic review and meta-analysis","volume":"69","year":"2017","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"2","key":"key20190222100150_R72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1071\/HC15946","article-title":"Deprescribing in a family health team: a study of chronic proton pump inhibitor use","volume":"8","year":"2016","journal-title":"Journal of Primary Health Care"},{"issue":"6","key":"key20190222100150_R73","doi-asserted-by":"crossref","first-page":"e015735","DOI":"10.1136\/bmjopen-2016-015735","article-title":"Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans","volume":"7","year":"2017","journal-title":"BMJ Open"}],"container-title":["Nursing Standard"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.rcni.com\/doi\/pdf\/10.7748\/ns.2019.e11249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T08:51:01Z","timestamp":1551257461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.rcni.com\/doi\/10.7748\/ns.2019.e11249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,22]]}},"alternative-id":["10.7748\/ns.2019.e11249"],"URL":"https:\/\/doi.org\/10.7748\/ns.2019.e11249","relation":{},"ISSN":["0029-6570","2047-9018"],"issn-type":[{"value":"0029-6570","type":"print"},{"value":"2047-9018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]}}}